Top 5 Revenue Growth by Industry Top Five Revenue: Generic Drugs 6/1/10 Welcome to our Top 5 Revenue page, which lists the top stocks based on Revenue Growth in certain industries each week. This week we look at Generic Drugs. Only U.S. companies are shown. Growth rates are calculated on the trailing twelve month period. These stocks are taken from a screening program and are not recommended to buy or sell. Further investigation is most appropriate before acting on this information.
INDUSTRY: Generic Drugs | | Company Name | Ticker | Revenue
Growth | Size | | | Par Pharmaceutical | PRX | 106.4% | $.97B | | | Hi-Tech Pharm. | HITK | 75.2% | $.28B | | | Watson Pharm. | WPI | 10.2% | $6.0B | | | Mylan | MYL | -0.9% | $6.0B | | | SeraCare Life Sci. | SRLS | -9.3% | $.09B |
DISCLAIMER: Information has been obtained from sources deemed to be reliable, but The Online Investor makes no guarantee as to the accuracy or completeness of this data. Information is provided for informational purposes only, and The Online Investor shall not be liable for any errors or omissions, or for any actions taken in reliance thereon. |
Weekly Newsletter
printer-friendly format